Navigation Links
Stemedica Requests Pre-IND Meeting With FDA
Date:8/21/2009

SAN DIEGO, Aug. 21 /PRNewswire/ -- Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke.

Stroke is a leading cause of adult impairment, with 20% of stroke survivors requiring institutional care after 3 months and up to 30% severely and permanently disabled. The only approved treatments of acute ischemic stroke involves restoring blood flow to the affected region by using thrombolytics or mechanical devices that physically remove clots. However, the use of thrombolytics (tPA) is limited due to the therapeutic window of < 3-6 hours post onset of stroke symptoms such that only a small fraction of stroke patients receive this therapy.

"Following a stroke, there is little therapy to offer patients to promote recovery other than physical, occupational, and speech therapy," said Nikolai Tankovich, MD, PhD, President & Chief Medical Officer. "Treatment with allogeneic mesenchymal bone marrow cells may offer new hope to patients with chronic neurological or age-related, neurodegenerative diseases."

Allogeneic mesenchymal bone marrow cells are obtained from donors by extracting bone marrow and are expanded at Stemedica's cGMP compliant facility, which is licensed by the California Department of Public Health, Food and Drug Branch. "Stemedica's facility will manufacture clinical grade stem cells as it prepares for FDA approval of an IND to begin clinical trials," said Maynard Howe, PhD, Vice Chairman and CEO of Stemedica.

About Stemedica C
'/>"/>

SOURCE Stemedica Cell Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
2. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
3. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
8. Biopure Reports on Meeting with the FDA
9. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
(Date:10/1/2014)... Calif. , Oct. 1, 2014 /PRNewswire/ ... ), a clinical-stage biopharmaceutical company focused on ... positive results from its 371 patient Phase ... with constipation-predominant irritable bowel syndrome (IBS-C).  Results ... clinically meaningful improvement in IBS-C symptoms for ...
(Date:10/1/2014)... LAUSANNE , Switzerland , October ... European leader in Clinical Genomics and Next Generation Sequencing ... Solution allowing clinicians to run full cystic fibrosis analysis ... covers the identification and characterisation of all types of ... analytical performance. Until now, it has not ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... , BROOKFIELD, Wis. , ... human resources and recruitment outsourcing company, today announced the addition ... Kaiser Permanente Mid-Atlantic States Region, to its Healthcare Advisory Board. ... during this time of monumental change in the healthcare industry. ...
... , MELVILLE, N.Y. , Jan. 25 ... HSIC ), the largest distributor of health care products and services ... of Bradley T. Sheares , Ph.D. to the Company,s Board ... Sheares brings a wealth of health care experience to the Henry ...
Cached Medicine Technology:Pinstripe Welcomes Carrie Harris-Muller To Board 2Pinstripe Welcomes Carrie Harris-Muller To Board 3Pinstripe Welcomes Carrie Harris-Muller To Board 4Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 2Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 3Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 4Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 5
(Date:10/1/2014)... This October, Request A Test , a leading national ... off all testing for Diabetes . Customers can ... The Center for Disease Control (CDC) reports that 25.8 ... Because many people do not display symptoms, it is ... health problems. Blood testing can help a person screen ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 This weekend Pope ... the elderly. Speaking to 40,000 seniors in St. ... abandonment of the elderly. "Violence against the elderly is ... "How many times are old people just discarded, victims of ... the result of a throw-away culture that is hurting our ...
(Date:10/1/2014)... NB (PRWEB) October 01, 2014 Indosoft, Inc., ... Q-Suite, announces that it has added support for ... Both Sangoma and Indosoft have a history of ... Sangoma's patent-pending technology offers a significant benefit to those ... AMD that is now available to users of Q-Suite. , ...
(Date:10/1/2014)... 2014 To help raise awareness about women’s ... Integrative Medicine, is detailing several tips for women looking to ... to Dr. Cutler, women should start each day with meditation, ... that will help ‘center’ yourself for the rest of the ... , Other health and fitness tips include:, -Drink half ...
(Date:9/30/2014)... at the same time could stop them from becoming ... Cancer Research * today (Wednesday). , ... funded by MedImmune, the global biologics research and development ... combining the two treatments helped the immune system hunt ... the initial radiotherapy in mice with breast, skin and ...
Breaking Medicine News(10 mins):Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 2Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 3Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 3Health News:Indosoft Announces Q-Suite Support For Sangoma Lyra 2Health News:In Recognition of National Women’s Health and Fitness Day, Cutler Integrative Medicine Details Tips for Living a Healthier and Happier Life 2Health News:Immunotherapy could stop resistance to radiotherapy 2
... ... and the Lake County Health Department targets underserved communities in North Chicago that are ... hundred people who cannot afford treatment. , ... Evanston, IL (PRWeb) July 7, 2010 -- NorthShore ...
... people with HIV/AIDS will provide significant cost savings over ... formal economic analysis led by researchers at the BC ... Care and the University of British Columbia (UBC). ... recently in AIDS , the official journal of ...
... As an ... help evaluate graduate programs to determine if they meet required standards for accreditation. Graduates ... , ... The American Dental Associations Commission ,on Dental Accreditation (CODA) has appointed Joseph R. Cohen, ...
... patients who participate in longer󈝻- to 30-minute discussions prior ... process) better understand the proposed operation, according to ... Journal of the American College of Surgeons . ... "repeat back" their understanding of the procedure was effective ...
... , ... Petter M. Etholm, CEO of Zone Labs, marketers of Zone Diet products, discussed entrepreneurial ... time radio show. , ... Lexington, KY (Vocus) July 7, 2010 -- “America is the land of educational ...
... Gardner HealthDay Reporter , WEDNESDAY, July 7 (HealthDay ... communicated with their doctors via e-mail got better care and ... as a result of the e-mail exchanges included such measures ... report appearing in Health Affairs . The ...
Cached Medicine News:Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 2Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 3Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 4Health News:New Diabetes Treatment Program Improves Health of Diabetes Patients and Their Families 5Health News:HIV prevention strategy key to curbing epidemic and cutting long-term treatment costs 2Health News:HIV prevention strategy key to curbing epidemic and cutting long-term treatment costs 3Health News:Phoenix Dentist Joseph R. Cohen, D.D.S., is Chosen by The American Dental Association's Commission on Dental Accreditation as Site Visitor. 2Health News:Study finds patients benefit from thorough discussion of recommended operations 2Health News:Study finds patients benefit from thorough discussion of recommended operations 3Health News:Zone Labs' CEO Etholm Discusses Entrepreneurial Opportunity in America, on WMST Radio 2Health News:Doctor-Patient E-Mails Are a Healthy Addition, Research Shows 2Health News:Doctor-Patient E-Mails Are a Healthy Addition, Research Shows 3
... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
... pause of a heartbeat. The bodys warmth ... breathing. These vital signs are yours to ... line of Temperature Monitoring products helps you ... needed to provide the most comfortable and ...
... is a portable, compact, lightweight system with ... emitting the same intensity (50 mW/cm) of ... smaller treatment area (30 cm). Excilite- possesses ... satisfy the most demanding professional users. The ...
... Smart 1064 is a laser system with ... versions with maximum continuous intensities of either 60 ... valid ally in all-mini-invasive surgical techniques. This laser ... it is the most requested from hospitals and ...
Medicine Products: